揿针治疗早中期老年膝骨关节炎疗效观察

Observations on the Clinical Efficacy of Thumb-tack Needle Therapy for the Early and Middle Stages of Senile Knee Osteoarthritis

目的观察揿针治疗早中期老年膝骨关节炎的临床疗效。方法将60例患者按随机数字表法分为观察组和对照组,每组30例。对照组予口服美洛昔康片,每次7.5 mg,每日1次;观察组在对照组基础上予揿针治疗,取患侧梁丘、膝阳关、内膝眼、犊鼻、阴陵泉、阳陵泉、阿是穴等,每次8 h,每日1次。两组均1星期治疗5次,连续治疗2星期。观察两组治疗前后WOMAC评分及Lysholm评分,并评价临床疗效。结果观察组和对照组的总有效率分别为93.3%、80.0%,观察组高于对照组,差异有统计学意义(P<0.05);治疗后两组WOMAC评分较治疗前下降,Lysholm评分较治疗前上升,差异有统计学意义(P<0.05);治疗后观察组WOMAC评分和Lysholm评分改善均优于对照组,差异有统计学意义(P<0.05)。结论揿针配合药物治疗早中期老年膝骨关节疗效确切,并能减轻患者疼痛,改善患者膝关节功能。

Objective To investigate the clinical efficacy of thumb-tack needle therapy for the early and middle stages of senile knee osteoarthritis.Method Sixty patients were allocated, using a random number table, to observation and control groups, 30 cases each.Thecontrol group took meloxicam tablets7.5 mg once daily and the observation group received thumb-tack needle therapy8 hrs once daily inaddition.Liangqiu（ST34）, Xiyangguan（GB33）, Neixiyan（Ex-LE4）, Dubi（ST35）, Yinlingquan（SP9）,Yanglingquan（GB34）and Ashipoint were selected forthumb-tack needle therapy.Both groups were treated five times a week for two consecutive weeks.The WOMAC score and the Lysholm score were recorded before and after treatment.Theclinical therapeutic effects were evaluated.Result The total efficacy rate was 93.3% inthe observation group and 80.0% in the control group.It was higher inthe observation group thanin the control group and there was a statistically significant difference （P〈0.05）. The WOMAC score decreased and the Lysholm score increased in both groups after treatment; there were statistically significant pre-/post-treatment differences （P〈0.05）.after treatment, the WOMAC score and the Lysholm score improved more inthe observation group than in the control group; there were statistically significant differences （P〈0.05）.Conclusion Thumb-tack needle therapyhas a definite effect on the early and middle stages of senile knee osteoarthritis.It can relieve the pain and improveknee functionin the patients.